Valuation : Manhattan Scientifics, Inc.

Market Cap 336K 289K 273K 248K 464K 32.03M 469K 3.24M 1.25M 16.3M 1.26M 1.23M 51.81M P/E 2022
-1.64x
P/E 2023 -1.25x
Enterprise Value 329K 283K 267K 243K 455K 31.36M 459K 3.18M 1.22M 15.96M 1.23M 1.21M 50.73M EV / Sales 2022
88,184,960x
EV / Sales 2023 -
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
1 day+9,900.00%
1 week+9,900.00%
1 month+9,900.00%
3 months+9,900.00%
6 months+9,900.00%
Current year+9,900.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.01
5 years 0
Extreme 1.0E-6
0.03
10 years 0
Extreme 1.0E-6
0.06
Manager TitleAgeSince
Chief Executive Officer 74 2007-10-31
President 89 1997-12-31
Director TitleAgeSince
Chairman 89 -
Chairman 74 2007-10-31
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%+9,900.00%+9,900.00%-98.18% 55.93K
-0.73%0.00%+12.71%+45.20% 562M
+0.82%-0.97%+12.87%-4.36% 395M
+1.77%+0.71%-6.18%-2.03% 115M
+0.19%+21.98%+611.41%+783.33% 55.95M
Average +1,980.41%+1,983.94%+2,106.16%+144.79% 225.51M
Weighted average by Cap. +0.60%+1.21%+41.04%+59.64%

Financials

2022 2023
Net sales 0.05 0.04 0.04 0.04 0.07 4.77 0.07 0.48 0.19 2.43 0.19 0.18 7.72 -
Net income -2.73M -2.35M -2.22M -2.02M -3.78M -261M -3.81M -26.4M -10.16M -133M -10.25M -10.03M -421M -1.16M -1M -947K -862K -1.61M -111M -1.63M -11.27M -4.33M -56.58M -4.37M -4.28M -180M
Net Debt -65K -55.99K -52.85K -48.11K -89.92K -6.2M -90.81K -629K -242K -3.16M -244K -239K -10.04M -7K -6.03K -5.69K -5.18K -9.68K -668K -9.78K -67.69K -26.04K -340K -26.28K -25.71K -1.08M
Logo Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
Employees
1
Date Price Change Volume
26-09-09 US$0.000100 +9,900.00% 4,100
  1. Stock Market
  2. Stocks
  3. MHTX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!